Abstract

The receptor of vitamin D (VDR) is present in most non-skeletal human cells, suggesting its role beyond the bone and calcium metabolism. The relationship between vitamin D and the respiratory tract is a consequence of its activity in the immune system. Some gastrointestinal diseases, such as inflammatory bowel disease, coeliac disease, liver, pancreas or cardiac diseases, lead to vitamin D deficiency. Many studies indicate a correlation between vitamin D and diabetes. VDR and 1α-hydroxylase have been detected in the cutaneous capillary vessels, endothelium, vascular smooth muscles, myocytes and cardiac fibroblasts. The influence of vitamin D on the expression of genes related to the vascular walls implies its role in the pathomechanisms of vascular diseases and the cardiovascular system. Due to the VDR detected in most immunocompetent cells, calcitriol can modulate the congenital and acquired immune system. The correlation between vitamin D and cancer development is also not surprising because of many functions which vitamin D has in the organism. The vitamin D-regulated genes encode the proteins which participate in differentiation, proliferation or apoptosis. This paper aims to focus on the less well known roles of vitamin D in the organism, especially considering that most “sun consumers” know only its antirachitic and bone reinforcing action. So, this article may be surprising, and first of all it should convince everyone to vitamin D supplemention.

References

• 1. Adams J.S., Ren S., Liu P.T., Chun R.F., Lagishetty V., GombartA.F., Borregaard N., Modlin R.L., Hewison M.: Vitamin D-directedrheostatic regulation of monocyte antibacterial responses. J. Immunol.,2009; 182: 4289-4295
  Google Scholar
• 2. Amital H., Shoenfeld Y.: Disease associations of vitamin D in autoimmunedisorders – prevention and therapy. Stand. Med., 2012;9: 620-622
  Google Scholar
• 3. Bailey R., Cooper J.D., Zeitels L., Smyth D.J., Yang J.H.M., WalkerN.M., Hyppönen E., Dunger D.B., Ramos-Lopez E., Badenhoop K.,Nejentsev S., Todd J.A.: Association of the vitamin D metabolismgene CYP27B1 with type 1 diabetes. Diabetes, 2007; 56: 2616-2621
  Google Scholar
• 4. Baynes K.C., Boucher B.J., Feskens E.J., Kromhout D.: Vitamin D,glucose tolerance and insulinaemia in elderly men. Diabetologia,1997; 40: 344-347
  Google Scholar
• 5. Bland R., Markovic D., Hills C.E., Hughes S.V., Chan S.L., SquiresP.E., Hewison M.: Expression of 25-hydroxyvitamin D3-1α-hydroxylase in pancreatic islets. J. Steroid Biochem. Mol. Biol.,2004; 89-90: 121-125
  Google Scholar
• 6. Bogołowska-Stieblich, Tałałaj M.: The role of vitamin D in thediseases of cardiovascular system. Postępy Nauk Med., 2012; 25:252-257
  Google Scholar
• 7. Borissova A.M., Tankova T., Kirilov G., Dakovska L., KovachevaR.: The effect of vitamin D3 on insulin secretion and peripheralinsulin sensitivity in type 2 diabetic patients. Int. J. Clin. Pract.,2003; 57: 258-261
  Google Scholar
• 8. Bourlon P.M., Billaudel B., Faure-Dussert A.: Influence of vitaminD3 deficiency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesisin the islets of the rat endocrine pancreas. J. Endocrinol.,1999; 160: 87-95
  Google Scholar
• 9. Bours P.H., Wielders J.P., Vermeijden J.R., van de Wiel A.: Seasonalvariation of serum 25-hydroxyvitamin D levels in adult patients withinflammatory bowel disease. Osteoporos. Int., 2011; 22: 2857-2867
  Google Scholar
• 10. Brehm J.M., Schuemann B., Fuhlbrigge A.L., Hollis B.W., StrunkR.C., Zeiger R.S., Weiss S.T., Litonjua A.A.: Serum vitamin D levels andsevere asthma exacerbations in the childhood asthma managementprogram study. J. Allergy Clin. Immunol., 2010; 126: 52-58
  Google Scholar
• 11. Chiang K.C., Yeh C.N., Hsu J.T., Chen L.W., Kuo S.F., Sun C.C., HuangC.C., Pang J.H., Flanagan J.N., Takano M., Kittaka A., Juang H.H.,Yang S.W., Chen T.C.: MART-10, a novel vitamin D analog, inhibitshead and neck squamos carcinoma cells growth through cell cyclearrest at G0/G1 with upregulation of p21 and p27 and downregulationof telomerase. J. Steroid Biochem. Mol. Biol., 2013; 138: 427-434
  Google Scholar
• 12. Chiu K.C., Chu A., Go V.L.W., Saad M.F.: Hypovitaminosis D is associatedwith insulin resistance and β cell dysfunction. Am. J. Clin.Nutr., 2004; 79: 820-825
  Google Scholar
• 13. Christakos S., Hewison M., Gardner D.G., Wagner C.L., SergeevI.N., Rutten E., Pittas A.G., Boland R., Ferrucci L., Bikle D.D.: VitaminD: beyond bone. Ann. N.Y. Acad. Sci., 2013; 1287: 45-58
  Google Scholar
• 14. Correale J., Ysrraelit M.C., Gaitán M.I.: Immunomodulatory effectsof vitamin D in multiple sclerosis. Brain, 2009; 132: 1146-1160
  Google Scholar
• 15. Correale J., Ysrraelit M.C., Gaitán M.I.: Gender differencesin 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiplesclerosis patients and healthy subjects. J. Immunol., 2010;185: 4948-4958
  Google Scholar
• 16. Correale J., Ysrraelit M.C., Gaitán M.I.: Vitamin D-mediated immuneregulation in multiple sclerosis. J. Neurol. Sci., 2011; 311; 23-31
  Google Scholar
• 17. Czerwiński E., Borowy P., Kumorek A.: Witamina D a układ mię-śniowo-szkieletowy. Stand. Med., 2012; 9: 649-654
  Google Scholar
• 18. Czerwiński E., Kumorek A.: Upadki, witamina D i złamania. PostępyNauk Med., 2012; 25: 226-231
  Google Scholar
• 19. Drechsler C., Pilz S., Obermayer-Pietsch B., Verduijn M., TomaschitzA., Krane V., Espe K., Dekker F., Brandenburg V., März W.,Ritz E., Wanner Ch.: Vitamin D deficiency is associated with suddencardiac, combined cardiovascular events, and mortality in haemodialysispatients. Eur. Heart J., 2010; 31: 2253-2261
  Google Scholar
• 20. Ferguson J.H., Chang A.B.: Vitamin D supplementation for cysticfibrosis. Cochrane Database Syst. Rev., 2014; 5: CD007298
  Google Scholar
• 21. Ginde A.A., Mansbach J.M., Camargo C.A.: Vitamin D, respiratoryinfections, and asthma. Curr. Allergy Asthma Rep., 2009; 9: 81-87
  Google Scholar
• 22. Ginde A.A., Mansbach J.M., Camargo C.A.Jr.: Association betweenserum 25-hydroxyvitamin D level and upper respiratory tractinfection in The Third National Health and Nutrition ExaminationSurvey. Arch. Intern. Med., 2009; 169: 384-390
  Google Scholar
• 23. Głuszko P.: Witamina D w reumatoidalnym zapaleniu stawów.Stand. Med., 2012; 9: 630-632
  Google Scholar
• 24. Gonzalo S.: Novel roles of 1α,25(OH)2D3 on DNA repair providenew strategies for breast cancer treatment. J. Steroid Biochem. Mol.Biol., 2014; 144: 59-64
  Google Scholar
• 25. Grey V., Atkinson S., Drury D., Casey L., Ferland G., Gundberg C.,Lands L.C.: Prevalence of low bone mass and deficiencies of vitaminsD and K in pediatric patients with cystic fibrosis from 3 Canadiancenters. Pediatrics, 2008; 122: 1014-1020
  Google Scholar
• 26. Gruber B.M., Anuszewska E.L.: Influence of vitamin D3 metaboliteson cell proliferation and cytotoxicity of adriamycin in humannormal and neoplastic cells. Toxicol. In Vitro, 2002; 16: 663-667
  Google Scholar
• 27. Holick C.N., Stanford J.L., Kwon E.M., Ostrander E.A., NejentsevS., Peters U.: Comprehensive association analysis of the vitamin Dpathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.Cancer Epidemiol. Biomarkers Prev., 2007; 16: 1990-1999
  Google Scholar
• 28. Hyppönen E., Power C.: Vitamin D status and glucose homeostasisin the 1958 British birth cohort: the role of obesity. DiabetesCare, 2006; 29: 2244-2246
  Google Scholar
• 29. Jasik A., Tałałaj M.: Witamina D a reumatoidalne zapalenie stawów.Postępy Nauk Med., 2012; 25: 237-240
  Google Scholar
• 30. Jones G.: Vitamin D safety: its mechanisms and application.Stand. Med., 2012; 9: 605-609
  Google Scholar
• 31. Kamei Y., Kawada T., Kazuki R., Ono T., Kato S., Sugimoto E.:Vitamin D receptor gene expression is up-regulated by 1,25-dihydroxyvitaminD3 in 3T3-L1 preadipocytes. Biochem. Biophys. Res.Commun., 1993; 193: 948-955
  Google Scholar
• 32. Karnchanasorn R., Ou H.Y., Chiu K.C.: Plasma 25-hydroxyvitaminD levels are favorably associated with β-cell function. Pancreas,2012; 41: 863-868
  Google Scholar
• 33. Kienreich K., Grübler M., Tomaschitz A., Schmid J., VerheyenN., Rutters F., Dekker J.M., Pilz S.: Vitamin D, arterial hypertension& cerebrovascular disease. Indian J. Med. Res., 2013; 137: 669-679
  Google Scholar
• 34. Kong J., Chen Y., Zhu G., Zhao Q., Li Y.C.: 1,25-dihydroxyvitaminD3 upregulates leptin expression in mouse adipose tissue. J. Endocrinol.,2013; 216: 265-271
  Google Scholar
• 35. Kong J., Kim G.H., Wei M., Sun T., Li G., Liu S.Q., Li X., Bhan S.,Zhao Q., Thadhani R., Li Y.C.: Therapeutic effects of vitamin D analogson cardiac hypertrophy in spontaneously hypertensive rats.Am. J. Pathol., 2010; 177: 622-631
  Google Scholar
• 36. Kong J., Zhang Z., Musch M., Ning G., Sun J., Hart J., BissonnetteM., Li Y.C.: Novel role of the vitamin D receptor in maintaining theintegrity of the intestinal mucosal barrier. Am. J. Physiol. Gastrointest.Liver Physiol., 2008; 294: G208-G216
  Google Scholar
• 37. Kotulska K., Bilska M.: Witamina D a stwardnienie rozsiane.Stand. Med., 2012; 9: 626-629
  Google Scholar
• 38. Kuźmińska M.: Witamina D a układ oddechowy. Postępy NaukMed., 2012; 25; 241-246
  Google Scholar
• 39. Larsen T., Mose F.H., Bech J.N., Hansen A.B., Pedersen E.B.: Effectof cholecalciferol supplementation during winter months in patientswith hypertension: a randomized, placebo-controlled trial. Am. J.Hypertens., 2012; 25: 1215-1222
  Google Scholar
• 40. Levin A.D., Wadhera V., Leach S.T., Woodhead H.J., LembergD.A., Mendoza-Cruz A.C., Day A.S.: Vitamin D deficiency in childrenwith inflammatory bowel disease. Dig. Dis. Sci., 2011; 56: 830-836
  Google Scholar
• 41. Li M., Hener P., Zhang Z., Kato S., Metzger D., Chambon P.: Topicalvitamin D3 and low-calcemic analogs induce thymic stromallymphopoietin in mouse keratinocytes and trigger an atopic dermatitis.Proc. Natl. Acad. Sci. USA, 2006; 103: 11736-11741
  Google Scholar
• 42. Liu W., Chen Y., Golan M.A., Annunziata M.L., Du J., DoughertyU., Kong J., Musch M., Huang Y., Pekow J., Zheng C., Bissonnette M.,Hanauer S.B., Li Y.C.: Intestinal epithelial vitamin D receptor signalinginhibits experimental colitis. J. Clin. Invest., 2013; 123: 3983-3996
  Google Scholar
• 43. Lorenc R.S., Karczmarewicz E., Kryśkiewicz E., Płudowski P.:Zasady suplementacji i standardy oceny zaopatrzenia organizmuw witaminę D w świetle jej działania plejotropowego. Stand. Med.,2012; 9: 595-604
  Google Scholar
• 44. Maestro B., Campión J., Dávila N., Calle C.: Stimulation by 1,25-dihydroxyvitaminD3 of insulin receptor expression and insulin responsivenessfor glucose transport in U-937 human promonocyticcells. Endocr. J., 2000; 47: 383-391
  Google Scholar
• 45. Maestro B., Dávila N., Carranza M.C., Calle C.: Identification ofa vitamin D response element in the human insulin receptor genepromoter. J. Steroid Biochem. Mol. Biol., 2003; 84: 223-230
  Google Scholar
• 46. Maestro B., Molero S., Bajo S., Dávila N., Calle C.: Transcriptionalactivation of the human insulin receptor gene by 1,25-dihydroxyvitaminD(3). Cell Biochem. Funct., 2002; 20: 227-232
  Google Scholar
• 47. Marcinowska-Suchowierska E.: Leczenie deficytów witaminyD u osób dorosłych w grupach ryzyka – “terapia szyta na miarę”.Stand. Med., 2012; 9: 716-721
  Google Scholar
• 48. Marcinowska-Suchowierska E., Sawicka A.: Wapń i witamina Dw prewencji złamań osteoporotycznych. Postępy Nauk Med., 2012;25: 273-279
  Google Scholar
• 49. Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadhani R.,Felsenfeld A., Levine B., Mehrotra R., Norris K.: Prevalence of cardiovascularrisk factors and the serum levels of 25-hydroxyvitaminD in the United States: data from the Third National Health and NutritionExamination Survey. Arch. Intern. Med., 2007; 167: 1159-1165
  Google Scholar
• 50. Misiorowski W.: Witamina D a cukrzyca typu 1 i 2 w wieku dojrzałym.Stand. Med., 2012; 9: 639-644
  Google Scholar
• 51. Mitri J., Dawson-Hughes B., Hu F.B., Pittas A.G.: Effects of vitaminD and calcium supplementation on pancreatic β cell function,insulin sensitivity, and glycemia in adults at high risk of diabetes: thecalcium and vitamin D for diabetes mellitus (CaDDM) randomizedcontrolled trial. Am. J. Clin. Nutr., 2011; 94: 486-494
  Google Scholar
• 52. Moukayed M., Grant W.B.: Molecular link between vitamin Dand cancer prevention. Nutrients, 2013; 5: 3993-4021
  Google Scholar
• 53. Norman P.E., Powell J.T.: Vitamin D, shedding light on the developmentof disease in peripheral arteries. Arterioscler. Thromb.Vasc. Biol., 2005; 25: 39-46
  Google Scholar
• 54. Odrowąż-Sypniewska G., Karczmarewicz E., Paprotny Ł., PłudowskiP.: 3-epi-25(OH)D – nowy metabolit, potencjalne działaniebiologiczne, problematyka interferencji w oznaczeniach. Stand.Med., 2012; 9: 680-686
  Google Scholar
• 55. Oh J.Y., Barrett-Connor E.: Association between vitamin D receptorpolymorphism and type 2 diabetes or metabolic syndromein community-dwelling older adults: the Rancho Bernardo Study.Metabolism, 2002; 51: 356-359
  Google Scholar
• 56. Pappa H.M., Mitchell P.D., Jiang H., Kassiff S., Filip-Dhima R., DiFabioD., Quinn N., Lawton R.C., Varvaris M., Van Straaten S., GordonC.: Treatment of vitamin D insufficiency in children and adolescentswith inflammatory bowel disease: a randomized clinical trial comparingthree regimens. J. Clin. Endocrinol. Metab., 2012; 97: 2134-2142
  Google Scholar
• 57. Parikh S., Edelman M., Uwaifo G.I., Freedman R.J., Semega-JannehM., Reynolds J., Yanovski J.A.: The relationship between obesityand serum 1,25-dihydroxy vitamin D concentrations in healthyadults. J. Clin. Endocrinol. Metab., 2004; 89: 1196-1199
  Google Scholar
• 58. Perzanowska-Brzeszkiewicz K., Marcinowska-Suchowierska E.:Witamina D a choroby przewodu pokarmowego. Postępy Nauk Med.,2012; 25: 247-251
  Google Scholar
• 59. Pilz S., Kienreich K., Tomaschitz A., Lerchbaum E., Meinitzer A.,März W., Zittermann A., Dekker J.M.: Vitamin D and cardiovasculardisease: update and outlook. Scand. J. Clin. Lab. Invest. Suppl.,2012; 243: 83-91
  Google Scholar
• 60. Pilz S., Kienreich K., Tomaschitz A., Ritz E., Lerchbaum E., Obermayer-PietschB., Matzi V., Lindenmann J., März W., Gandini S., Dekker J.M.:Vitamin D and cancer mortality: systematic review of prospective epidemiologicalstudies. Anticancer Agents Med. Chem., 2013; 13: 107-117
  Google Scholar
• 61. Pilz S. Tomaschitz A., März W., Drechsler C., Ritz E., ZittermannA., Cavalier E., Pieber T.R., Lappe J.M., Grant W.B., Holick M.F., DekkerJ.M.: Vitamin D, cardiovascular disease and mortality. Clin. Endocrinol.,2011; 75: 575-584
  Google Scholar
• 62. Pittas A.G., Dawson-Hughes B.: Vitamin D and diabetes. J. SteroidBiochem. Mol. Biol., 2010; 121: 425-429
  Google Scholar
• 63. Pittas A.G., Laskowski U., Kos L., Saltzman E.: The role of vitaminD in adults requiring nutrition therapy. J. Parenter. EnteralNutr., 2010; 34: 70-78
  Google Scholar
• 64. Pittas A.G., Lau J., Hu F., Dawson-Hughes B.: The role of vitaminD and calcium in type 2 diabetes. A systematic review and meta-analysis.J. Clin. Endocrinol. Metab., 2007; 92: 2017-2029
  Google Scholar
• 65. Pittas A.G., Sun Q., Manson J.E., Dawson-Hughes B., Hu F.B.: Plasma25-hydroxyvitamin D concentration and risk of incident type 2diabetes in women. Diabetes Care, 2010; 33: 2021-2023
  Google Scholar
• 66. Płudowski P., Karczmarewicz E., Bayer M., Carter G., Chlebna-SokółD., Czech-Kowalska J., Dębski R., Decsi T., Dobrzańska A., FranekE., Głuszko P., Grant W.B., Holick M.F., Yankovskaya L., KonstantynowiczJ. i wsp.: Practical guidelines for the supplementation of vitaminD and the treatment of deficits in Central Europe – recommendedvitamin D intakes in the general population and groups at risk ofvitamin D deficiency. Endokrynol. Pol., 2013; 64: 319-327
  Google Scholar
• 67. Płudowski P., Kryśkiewicz E., Karczmarewicz E.: Zasady suplementacjii standardy oceny zaopatrzenia organizmu w witaminę Dw świetle jej działania plejotropowego. Postępy Nauk Med., 2012;25: 265-272
  Google Scholar
• 68. Polskie zalecenia dotyczące profilaktyki niedoborów witaminyD – rok 2009. Stand. Med., 2009; 6: 875-879
  Google Scholar
• 69. Ross A.C., Manson J.E., Abrams S.A., Aloia J.F., Brannon P.M.,Clinton S.K., Durazo-Arvizu R.A., Gallagher J.C., Gallo R.L., Jones G.,Kovacs C.S., Mayne S.T., Rosen C.J., Shapses S.A.: The 2011 report ondietary reference intakes for calcium and vitamin D from the Instituteof Medicine: what clinicians need to know. J. Clin. Endocrinol.Metab., 2011; 96: 53-58
  Google Scholar
• 70. Rovner A.J., Stallings V.A., Schall J.I., Leonard M.B., Zemel B.S.:Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am. J. Clin.Nutr., 2007; 86: 1694-1699
  Google Scholar
• 71. Samochocki Z.: Czy witamina D ma wpływ na rozwój i przebiegatopowego zapalenia skóry? Stand. Med., 2012; 9: 623-625
  Google Scholar
• 72. Scragg R.: Vitamin D and type 2 diabetes. Are we ready for a preventiontrial? Diabetes, 2008; 57: 2565-2566
  Google Scholar
• 73. Socha P.: Witamina D w chorobach przebiegających z zaburzeniamiwchłaniania (mukowiscydoza, cholestaza, nieswoiste zapaleniejelit). Stand. Med., 2012; 9: 655-658
  Google Scholar
• 74. Soilu-Hänninen M., Aivo J., Lindström B.M., Elovaara I., SumelahtiM.L., Färkkilä M., Tienari P., Atula S., Sarasoja T., Herrala L., KeskinarkausI., Kruger J., Kallio T., Rocca M.A., Filippi M.: A randomised,double blind, placebo controlled trial with vitamin D3 as an add ontreatment to interferon β-1b in patients with multiple sclerosis. J.Neurol. Neurosurg. Psychiatry, 2012; 83: 565-571
  Google Scholar
• 75. Sun Q., Pan A., Hu F.B., Manson J.E., Rexrode K.M.: 25-hydroxyvitaminD levels and the risk of stroke. A prospective study andmeta-analysis. Stroke, 2012; 43: 1470-1477
  Google Scholar
• 76. Szalecki M., Lech M., Malinowska A.: Witamina D w cukrzycytypu 1 i 2 oraz w endokrynopatiach wieku rozwojowego. Stand.Med., 2012; 9: 633-638
  Google Scholar
• 77. Szeto F.L., Reardon C.A., Yoon D., Wang Y., Wong K.E., Chen Y.,Kong J., Liu S.Q., Thadhani R., Getz G.S., Li Y.C.: Vitamin D receptorsignaling inhibits atherosclerosis in mice. Mol. Endocrinol., 2012;26: 1091-1101
  Google Scholar
• 78. Targher G., Bertolini L., Scala L., Cigolini M., Zenari L., FalezzaG., Arcaro G.: Associations between serum 25-hydroxyvitamin D3concentrations and liver histology in patients with non-alcoholicfatty liver disease. Nutr. Metab. Cardiovasc. Dis., 2007; 17: 517-524
  Google Scholar
• 79. Thomas G.N., Scragg R., Jiang C.Q., Chan W., Marz W., Pilz S., KimH.C., Tomlinson B., Bosch J., Lam T.H., Cheung B.M., Cheng K.K.: Hyperglycaemiaand vitamin D: a systematic overview. Curr. DiabetesRev., 2012; 8: 18-31
  Google Scholar
• 80. Ulitsky A., Ananthakrishnan A.N., Naik A., Skaros S., ZadvornovaY., Binion D.G., Issa M.: Vitamin D deficiency in patients withinflammatory bowel disease: associations with disease activity andquality of life. J. Parenter. Enteral Nutr., 2011; 35: 308-316
  Google Scholar
• 81. Urashima M., Segawa T., Okazaki M., Kurihara M., Wada Y., Ida H.:Randomized trial of vitamin D supplementation to prevent seasonalinfluenza A in schoolchildren. Am. J. Clin. Nutr., 2010; 91: 1255-1260
  Google Scholar
• 82. Walentowicz-Sadłecka M., Grabiec M., Sadłecki P., WalentowiczP., Krintus M., Mańkowska-Cyl A., Odrowąż-Sypniewska G.: Ocenastężeń 25(OH)D3 u pacjentek z rakiem jajnika i ich związek z pię-cioletnimi przeżyciami. Prezentacje ustne. Stand. Med., 2012; 9: 722
  Google Scholar
• 83. Walicka M., Czerwińska E., Marcinowska-Suchowierska E.: WitaminaD – wpływ na kość. Postępy Nauk Med., 2012; 25: 232-236
  Google Scholar
• 84. Wang Y., Deb D.K., Zhang Z., Sun T., Liu W., Yoon D., Kong J.,Chen Y., Chang A., Li Y.C.: Vitamin D receptor signaling in podocytesprotects against diabetic nephropathy. J. Am. Soc. Nephrol.,2012; 23: 1977-1986
  Google Scholar
• 85. Wąsowski M., Czerwińska E., Marcinowska-Suchowierska E.:Otyłość – stan predysponujący do niedoborów witaminy D. PostępyNauk Med., 2012; 25: 258-264
  Google Scholar
• 86. Wong K.E., Kong J., Zhang W., Szeto F.L., Ye H., Deb D.K., BradyM.J., Li Y.C.: Targeted expression of human vitamin D receptor inadipocytes decreases energy expenditure and induces obesity inmice. J. Biol. Chem., 2011; 286: 33804-33810
  Google Scholar
• 87. Xu H., Li S., Qiu J.Q., Gao X.L., Zhang P., Yang Y.X.: The VDRgene FokI polymorphism and ovarian cancer risk. Tumour Biol.,2013; 34: 3309-3316
  Google Scholar
• 88. Xue L.N., Xu K.Q., Zhang W., Wang Q., Wu J., Wang X.Y.: Associationsbetween vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn’s disease: a meta-analysis. Inflamm.Bowel Dis., 2013; 19: 54-60
  Google Scholar
• 89. Yuan W., Pan W., Kong J., Zheng W., Szeto F.L., Wong K.E., CohenR., Klopot A., Zhang Z., Li Y.C.: 1,25-dihydroxyvitamin D3 suppressesrenin gene transcription by blocking the activity of the cyclicAMP response element in the renin gene promoter. J. Biol. Chem.,2007; 282: 29821-29830
  Google Scholar
• 90. Zeitz U., Weber K., Soegiarto D.W., Wolf E., Balling R., Erben R.G.:Impaired insulin secretory capacity in mice lacking a functional vitaminD receptor. FASEB J., 2003; 17: 509-511
  Google Scholar
• 91. Zheng W., Wong K.E., Zhang Z., Dougherty U., Mustafi R., Kong J.,Deb D.K., Zheng H., Bissonnette M., Li Y.C.: Inactivation of the vitaminD receptor in APCmin/+ mice reveals a critical role for the vitamin Dreceptor in intestinal tumor growth. Int. J. Cancer, 2012; 130: 10-19
  Google Scholar
• 92. Zhu Y., Mahon B.D., Froicu M., Cantorna M.T.: Calcium and alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppressexperimental inflammatory bowel disease. Eur. J. Immunol.,2005; 35: 217-224
  Google Scholar

Full text